Beneficial effects of olmesartan, a novel angiotensin II receptor type 1 antagonist, upon acute autoimmune myocarditis

By Nimata Masaomi   Kishimoto Chiharu   Yuan Zuyi   Shioji Keisuke  

Molecular and Cellular Biochemistry, Vol. 259, Iss. 1-2, 2004-04 ,pp. : 217-222

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics, metabolism and excretion of the glycine antagonist GV150526A in rat and dog

By Kajbaf M.   Barnaby R. J   Bottacini M.   Bertolotti L.   Ismail I. M   Cholerton T. J.   Pellegatti M.  

Xenobiotica, Vol. 33, Iss. 4, 2003-04 ,pp. : 415-428

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey: in vitro/in vivo correlation and the role of aldehyde oxidase

By Austin N. E.   Baldwin S. J.   Cutler L.   Deeks N.   Kelly P. J.   Nash M.   Shardlow C. E.   Stemp G.   Thewlis K.   Ayrton A.   Jeffrey P.  

Xenobiotica, Vol. 31, Iss. 8-9, 2001-08 ,pp. : 677-686

Informa Healthcare

Access to resources Recommend Favorite

Metabolism, pharmacokinetics and excretion of a potent tachykinin NK1 receptor antagonist (CP-122,721) in rat: Characterization of a novel oxidative pathway

By Kamel A.   Davis J.   Potchoiba M. J.   Prakash C.  

Xenobiotica, Vol. 36, Iss. 2-3, 2006-02 ,pp. : 235-258

Informa Healthcare

Access to resources Recommend Favorite

Role of Gβ-Subunit in Angiotensin II-Type 1 Receptor Signaling

By Luchtefeld M.   Drexler H.   Schieffer B.  

Biochemical and Biophysical Research Communications, Vol. 280, Iss. 3, 2001-01 ,pp. : 756-760

Elsevier

Access to resources Recommend Favorite